查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1739309

人工智慧医疗诊断应用的全球市场

Artificial Intelligence Medical Diagnosis App
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 172 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年，全球人工智慧医疗诊断应用市场规模将达33亿美元

全球人工智慧医疗诊断应用市场规模预计在2024年达到12亿美元，预计2024年至2030年期间的复合年增长率为19.0%，到2030年将达到33亿美元。云端部署是本报告分析的细分市场之一，预计其复合年增长率为17.1%，到分析期结束时规模将达到21亿美元。本地配置细分市场在分析期间的复合年增长率预计为22.9%。

美国市场规模估计为 3.061 亿美元，中国市场预计复合年增长率为 18.0%

美国人工智慧医疗诊断应用市场规模预计在2024年达到3.061亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到5.104亿美元，在2024-2030年的分析期内，复合年增长率将达到18.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为17.2%和16.6%。在欧洲，预计德国市场的复合年增长率约为14.2%。

全球人工智慧医疗诊断应用市场—主要趋势与驱动因素摘要

为什么基于人工智慧的医疗诊断应用程式成为数位健康转型的核心？

人工智慧 (AI) 驱动的医疗诊断应用程式正成为不断发展的数位医疗领域不可或缺的一部分，它们能够直接向患者和临床医生提供快速、便捷、数据驱动的主动诊断。这些应用程式使用机器学习演算法、影像识别、自然语言处理 (NLP) 和预测分析来评估症状、分析医疗数据并产生机率诊断和分诊建议。它们的效用在于能够及时洞察疾病的早期发现，减少不必要的临床就诊，并支持远距会诊，尤其是在初级保健、皮肤科、放射科、眼科和慢性病管理领域。

全球对以患者为中心的医疗服务、医疗保健去中心化以及数位化优先医疗系统的重视，正在推动此类解决方案的采用。 AI 诊断应用程式透过帮助使用者解读症状、确定护理路径的优先顺序以及导航至合适的医疗资源来提高效率。对于医疗服务提供者而言，这些工具透过协助鑑别诊断、自动化文件处理和标记高风险病例，改善了临床决策和诊疗效率。在医疗成本不断上涨、业务短缺的背景下，AI 驱动的诊断应用程式越来越被视为一种经济高效且可扩展的扩展第一线医疗服务的方式。

人工智慧模型和医疗数据生态系统如何提高诊断准确性？

人工智慧模型开发及其与临床数据生态系统整合的进步，显着提升了医疗诊断应用程式的准确性和可用性。基于大型去识别化资料集（包括电子健康记录(EHR)、影像檔案、实验室结果和患者报告资料）训练的监督学习演算法，使这些应用程式能够识别疾病模式、识别合併症并提供针对特定疾病的风险评估。自然语言处理 (NLP) 演算法支援症状检查介面，该介面可解释自由文字输入，并使用 SNOMED CT 和 ICD-10 等临床本体来提案可能的疾病。

深度学习和卷积类神经网路(CNN) 在视觉诊断领域特别有效，例如在皮肤科影像中检测皮肤癌，在视网膜扫描中识别糖尿病视网膜病变，以及在胸部 X 光片中分析肺炎和结核病。一些应用程式正在整合穿戴式装置和感测器数据，在心律不整检测、睡眠障碍和呼吸监测等领域提供即时诊断。云端基础平台能够根据新的临床证据和使用者回馈进行即时更新和模型再训练，从而提升应用程式的适应性。随着资料互通性和联邦学习的成熟，这些应用程式正变得更加准确、可解释，并符合临床检验标准。

市场需求在哪里加速成长以及哪些使用案例正在引领采用？

已开发市场和新兴市场对基于人工智慧的医疗诊断应用的需求都在快速增长，其中美国、欧洲和亚太地区尤为突出。在北美，远端医疗的整合、智慧型手机的高普及率以及数位疗法和人工智慧临床工具日益增长的监管势头，正在推动应用的普及。在欧洲，数位医疗改革和广泛的国有化医疗体系，使得人工智慧诊断应用能够融入公共医疗工作流程。同时，在亚太地区，行动装置使用率高、农村地区难以获得医疗专业人员以及政府主导的数位医疗倡议，正在推动应用的快速普及。

主要使用案例包括用于自我诊断的症状检查应用程式、客服中心和聊天机器人中使用的人工智慧分诊助理、皮肤科影像分析应用程式、眼科筛检应用程式以及放射科预筛检工具。慢性病管理应用程序，尤其是针对糖尿病、高血压和气喘的应用程序，也正在整合人工智慧来解读生物特征资讯并提案即时干预建议。基于语音和脸部表情分析的心理健康诊断是新的前沿领域。企业应用程式也不断扩展，保险公司和医院网路正在部署人工智慧应用程序，以减少欺诈性索赔、优化病人历程，并在远端患者监护程序中标记早期预警信号。

是什么推动了人工智慧医疗诊断应用的全球成长？

AI医疗诊断应用市场的成长受到多个关键因素的推动，包括消费者对按需健康资讯的需求不断增长、慢性病盛行率不断上升，以及人工智慧、行动运算和医学影像领域的技术进步。关键驱动因素包括数位健康平台的整合、患者赋权趋势，以及对可扩展解决方案的需求，以弥合都市区和服务不足地区的诊断差距。 COVID-19疫情表明，远距离诊断是分诊、检测和追踪的重要工具，这进一步加速了其应用。

资金筹措、医疗技术加速器以及人工智慧新兴企业、医疗技术公司和医疗保健提供者之间的策略伙伴关係正在刺激快速创新和商业化。 FDA 和 CE 等监管机构越来越多地为临床级人工智慧应用程式核准提供清晰的框架，符合 HIPAA/GDPR 的架构解决了隐私和信任障碍。与 EHR、远端医疗平台 API 和多语言介面的整合使这些应用程式更加用户友好且具有上下文感知能力。随着人工智慧诊断工具从症状检查器发展到针对特定症状的诊断助手，一个关键问题出现了：人工智慧驱动的诊断应用程式能否提供安全、公正且经过临床检验的解决方案？

部分

配置（云端、本地）；应用（放射学、病理学、循环系统、皮肤病学和其他应用）；最终用户（医院、诊断中心、诊所和其他最终用户）

受访公司范例（值得关注的36家公司）

  • Ada Health
  • AI Medical Service
  • AIDoc
  • AliveCor
  • Arterys
  • Babylon Health
  • Bay Labs
  • Binah.ai
  • Buoy Health
  • Butterfly Network
  • Caption Health
  • Corti
  • Eko Health
  • Enlitic
  • GE Healthcare
  • Google Health
  • IBM Watson Health
  • iCAD
  • Infermedica
  • Lunit

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口（成品和原始OEM）来预测其竞争地位的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、盈利下降、供应链重组以及其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家（14,949位）、智库（62家）以及贸易和产业协会（171家）的专家的意见，以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计，这场动盪将在未来2-3个月内逐渐平息，新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月：谈判阶段

在4月的报告中，我们将探讨关税对全球整体市场的影响，并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将在 7 月收到免费更新，最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪了 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家，他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP33466

Global Artificial Intelligence Medical Diagnosis App Market to Reach US$3.3 Billion by 2030

The global market for Artificial Intelligence Medical Diagnosis App estimated at US$1.2 Billion in the year 2024, is expected to reach US$3.3 Billion by 2030, growing at a CAGR of 19.0% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the On-Premise Deployment segment is estimated at 22.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$306.1 Million While China is Forecast to Grow at 18.0% CAGR

The Artificial Intelligence Medical Diagnosis App market in the U.S. is estimated at US$306.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$510.4 Million by the year 2030 trailing a CAGR of 18.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.2% and 16.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.2% CAGR.

Global Artificial Intelligence Medical Diagnosis App Market - Key Trends & Drivers Summarized

Why Are AI-Based Medical Diagnosis Apps Becoming Central to Digital Health Transformation?

Artificial Intelligence (AI)-powered medical diagnosis apps are becoming integral to the evolving landscape of digital healthcare by delivering rapid, accessible, and data-driven preliminary diagnostics directly to patients and clinicians. These apps use machine learning algorithms, image recognition, natural language processing (NLP), and predictive analytics to assess symptoms, analyze medical data, and generate probabilistic diagnoses or triage recommendations. Their utility lies in offering timely insights for early disease detection, reducing unnecessary clinical visits, and supporting remote care delivery-especially in primary care, dermatology, radiology, ophthalmology, and chronic disease management.

The global emphasis on patient-centered care, healthcare decentralization, and digital-first medical systems is propelling adoption of these solutions. AI diagnostic apps enhance efficiency by helping users interpret symptoms, prioritize care pathways, and navigate to appropriate healthcare resources. For healthcare providers, these tools assist in differential diagnosis, automate documentation, and flag high-risk cases, thereby improving clinical decision-making and operational throughput. Amid rising healthcare costs and physician shortages, AI-powered diagnostic applications are increasingly viewed as cost-effective, scalable extensions of frontline medical services.

How Are AI Models and Medical Data Ecosystems Enhancing Diagnostic Precision?

Advancements in AI model development and integration with clinical data ecosystems are significantly improving the accuracy and usability of medical diagnosis apps. Supervised learning algorithms trained on large, anonymized datasets-from electronic health records (EHRs), imaging archives, lab results, and patient-reported data-enable these apps to recognize disease patterns, identify comorbidities, and offer condition-specific risk assessments. Natural language processing (NLP) algorithms power symptom-checker interfaces that interpret free-text input and suggest likely conditions using clinical ontologies such as SNOMED CT and ICD-10.

Deep learning and convolutional neural networks (CNNs) are especially impactful in visual diagnostics-such as detecting skin cancer from dermatology images, identifying diabetic retinopathy in retinal scans, or analyzing chest X-rays for pneumonia or tuberculosis. Some apps integrate wearable and sensor data to provide real-time diagnostics in areas like arrhythmia detection, sleep disorders, and respiratory monitoring. Cloud-based platforms are enabling real-time updates and model retraining based on new clinical evidence and user feedback, enhancing app adaptability. As data interoperability and federated learning mature, these apps are becoming more accurate, explainable, and compliant with clinical validation standards.

Where Is Market Demand Accelerating and Which Use Cases Are Leading Adoption?

Market demand for AI-based medical diagnosis apps is growing rapidly in both developed and emerging markets, with significant traction in the U.S., Europe, and Asia-Pacific. In North America, adoption is driven by telemedicine integration, high smartphone penetration, and favorable regulatory momentum toward digital therapeutics and AI-enabled clinical tools. In Europe, digital health reforms and widespread use of national health systems are enabling integration of AI diagnostic apps into public healthcare workflows. Meanwhile, Asia-Pacific is seeing fast adoption due to high mobile usage, limited access to healthcare professionals in rural areas, and government-led digital health initiatives.

Leading use cases include symptom-checker apps for self-assessment, AI-powered triage assistants used in call centers or chatbots, dermatology image analyzers, ophthalmic screening apps, and radiology pre-screening tools. Chronic condition management apps, especially for diabetes, hypertension, and asthma, are also incorporating AI to interpret biometrics and suggest real-time interventions. Mental health diagnostics based on speech and facial expression analytics are an emerging frontier. Enterprise use is also growing, with insurers and hospital networks deploying AI apps to reduce claims fraud, optimize patient journeys, and flag early warning signs in remote patient monitoring programs.

What Is Driving the Global Growth of AI Medical Diagnosis Apps?

The growth in the AI medical diagnosis app market is driven by several key factors, including rising consumer demand for on-demand health information, increasing chronic disease prevalence, and technological advancements in AI, mobile computing, and medical imaging. A critical driver is the convergence of digital health platforms, patient empowerment trends, and the need for scalable solutions to bridge diagnostic gaps in both urban and underserved regions. COVID-19 further accelerated adoption by validating remote diagnostics as essential tools for triaging, testing, and follow-up.

Venture funding, healthtech accelerators, and strategic partnerships between AI startups, medtech firms, and healthcare providers are fueling rapid innovation and commercialization. Regulatory bodies like the FDA and CE are increasingly providing clear frameworks for clinical-grade AI app approval, while HIPAA/GDPR-compliant architectures are addressing privacy and trust barriers. Integration with EHRs, APIs for telehealth platforms, and multilingual interfaces are making these apps more usable and context-aware. As AI diagnostic tools evolve from symptom checkers to condition-specific diagnostic assistants, a key question arises: Can artificial intelligence-powered diagnosis apps deliver safe, equitable, and clinically validated solutions that extend diagnostic intelligence beyond the clinic and into the hands of every user?

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence Medical Diagnosis App market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Deployment (Cloud, On-Premise); Application (Radiology, Pathology, Cardiology, Dermatology, Other Applications); End-User (Hospitals, Diagnostic Centers, Clinics, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • Ada Health
  • AI Medical Service
  • AIDoc
  • AliveCor
  • Arterys
  • Babylon Health
  • Bay Labs
  • Binah.ai
  • Buoy Health
  • Butterfly Network
  • Caption Health
  • Corti
  • Eko Health
  • Enlitic
  • GE Healthcare
  • Google Health
  • IBM Watson Health
  • iCAD
  • Infermedica
  • Lunit

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Artificial Intelligence Medical Diagnosis App - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Smartphone-Based AI Medical Diagnosis Apps Democratize Access to Early Health Screening
    • Clinical-Grade Algorithms Drive Accuracy of AI Medical Diagnosis Apps in Real-World Settings
    • AI-Powered Apps Expand Telehealth Capabilities With Instant Diagnostic Support
    • Symptom Checkers Integrated With AI Apps Enhance Patient Triage and Navigation
    • Remote Monitoring Features Embedded in AI Diagnosis Apps Improve Chronic Disease Management
    • Regulatory Validation and CE/FDA Approvals Boost Trust in AI-Powered Diagnosis Apps
    • Multi-Language and Voice Recognition Features Improve AI App Accessibility in Diverse Populations
    • Behavioral Health and Dermatology Emerge as Key Focus Areas for AI Medical Diagnosis Apps
    • Real-Time Feedback and Learning Loops Enhance Diagnostic Precision in AI Health Apps
    • Wearable Sync Capabilities Augment Data Streams for AI Diagnosis Applications
    • Consumer Health Ecosystems Evolve Around AI Medical Apps for Proactive Wellness Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence Medical Diagnosis App Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Pathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Dermatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030

IV. COMPETITION